1Johnston A, Uren E, Johnstone D, et al. Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies. Biologicals, 2003,31: 213-221. 被引量：1
2Hoffer L,Schwinn H,Josi'c Dj,et al.Production of highly purified clotting factorⅨ by a combination of different chromatographic methods[J].J Chromatogr A,1999,844(1～2):119 被引量：1
3Husi H,Walkinshaw MD.Purification of factor Ⅹ by hydrophobic interaction chromatography[J].J Chromatogr B,2001,755(1～2):367 被引量：1
4Husi H,Walkinshaw MD.Separation of human vitamin K-dependent Coagulation proteins using hydrophobic interaction chromatography[J].J Chromatogr B,1999,736(1～2):77 被引量：1
5Rainer S,Johannes D.Virus safety of prothrombin complex concentrates and factor Ⅸ concentrates[J].Thromb Res,1999,95(4):S19 被引量：1
6Chandra S,Groener A,Feldman F.Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products[J].Thromb Res,2002,105(5):391 被引量：1
7Johnston A,Adcock W.The use of chromatography to manufacture purer and safer plasma products[J].Biotech Genet Eng Rev,2000,17(1):37 被引量：1
8Roberts PL,Dunkerley C.Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor Ⅸ concentrate[J].Vox Sang,2003,84(3):170 被引量：1
9Johnston A,MacGregor A,Borovec S,et al.Inactivation and clearance of viruses during the manufacture of high purity factor Ⅸ[J].Biologicals,2000,28(3):129 被引量：1
10Roberts P,Hope A.Virus inactivation by high intensity broad spectrum pulsed light[J].J Virol Methods,2003,110(1):61 被引量：1
